ADAR1 Capital Management »

Gh Research shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Gh Research (GHRS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Gh Research

Tip: Access up to 7 years of quarterly data

All positions including Gh Research held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gh Research by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $134k 13k 10.66

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Gh Research

BVF
RA Capital Management
Lynx1 Capital Management
Verition Fund Management
Cormorant Asset Management
5AM Venture Management
Morgan Stanley
Citadel Advisors
Geode Capital Management
BlackRock
BlackRock
Laurion Capital Management
ALPS Advisors
Woodline Partners
Northern Trust

View all funds holding Gh Research